UNIVERSITY OF ARIZONA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-01-01

Employees: 10K

Market Cap: -

Website: http://www.arizona.edu

Clinical Trials

Diagnosis of Exercise-induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes

Completed

Conditions: Exercise Induced Bronchospasm, Asthma

First Posted Date: 2008-09-15

Last Posted Date: 2016-05-12

Lead Sponsor: University of Arizona

Target Recruit Count: 74

Registration Number: NCT00752167

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States

Selenium in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Other: placebo
Dietary Supplement: selenium

First Posted Date: 2008-09-15

Last Posted Date: 2012-08-15

Lead Sponsor: University of Arizona

Target Recruit Count: 220

Registration Number: NCT00752739

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan in Patients W/Relapsed Stage II, III, or IV Follicular NHL

Phase 2

Completed

Conditions: Lymphoma

Interventions: Drug: Methylprednisolone
Drug: Etoposide
Drug: Cytarabine
Drug: Cisplatin
Drug: Rituximab
Drug: In-Zevalin
Drug: Y-Zevalin

First Posted Date: 2008-08-12

Last Posted Date: 2019-09-04

Lead Sponsor: University of Arizona

Target Recruit Count: 28

Registration Number: NCT00732498

Locations: 🇺🇸
The University of Arizona Cancer Center, Tucson, Arizona, United States

Alimta® Plus Cisplatin & Paclitaxel Given Intraperitonelly; First Line Tx Stage III Ovarian Cancer

Phase 1

Completed

Conditions: Fallopian Tube Cancer
Peritoneal Cavity Cancer
Ovarian Cancer

Interventions: Drug: cisplatin
Drug: paclitaxel
Drug: pemetrexed disodium
Other: biologic sample preservation procedure

First Posted Date: 2008-06-20

Last Posted Date: 2016-01-01

Lead Sponsor: University of Arizona

Target Recruit Count: 15

Registration Number: NCT00702299

Locations: 🇺🇸
Arizona Oncology - Scottsdale, Scottsdale, Arizona, United States
🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer

Phase 1

Completed

Conditions: Esophageal Cancer

Interventions: Drug: cisplatin
Drug: Pemetrexed
Radiation: radiation therapy

First Posted Date: 2008-06-19

Last Posted Date: 2016-04-20

Lead Sponsor: University of Arizona

Target Recruit Count: 10

Registration Number: NCT00701857

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Cancer

Interventions: Drug: flutamide

First Posted Date: 2008-06-18

Last Posted Date: 2018-07-24

Lead Sponsor: University of Arizona

Target Recruit Count: 127

Registration Number: NCT00699907

Locations: 🇺🇸
University of Arizona Cancer Center, Tucson, Arizona, United States

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Phase 2

Terminated

Conditions: Hematologic Neoplasms
Hodgkin's Disease
Lymphoma
Carcinoma, Renal Cell
Leukemia
Multiple Myeloma

Interventions: Drug: Pentostatin
Biological: Alemtuzumab
Procedure: Allogeneic hematopoietic stem cell transplantation

First Posted Date: 2008-06-17

Last Posted Date: 2017-03-31

Lead Sponsor: University of Arizona

Target Recruit Count: 14

Registration Number: NCT00698685

Locations: 🇺🇸
Arizona Cancer Center at UMC North, Tucson, Arizona, United States
🇺🇸
Arizona Cancer Center at UMC North/University Medical Center, Tucson, Arizona, United States

Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Etoposide
Drug: Irinotecan hydrochloride

First Posted Date: 2008-06-09

Last Posted Date: 2015-11-20

Lead Sponsor: University of Arizona

Target Recruit Count: 31

Registration Number: NCT00693719

Locations: 🇺🇸
Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, United States

Echinacea Purpurea and Osteopathy in Children With Recurrent Otitis Media

Not Applicable

Completed

Conditions: Otitis Media

Interventions: Procedure: Sham osteopathic manipulative treatment
Procedure: Cranial osteopathic manipulative treatment.
Dietary Supplement: Echinacea purpurea
Dietary Supplement: "Echinacea purpurea" placebo

First Posted Date: 2008-06-03

Last Posted Date: 2008-06-03

Lead Sponsor: University of Arizona

Target Recruit Count: 90

Registration Number: NCT00689468

Locations: 🇺🇸
KateCare Osteopathic Center, Tucson, Arizona, United States
🇺🇸
Pediatric Osteopathic Center, Tucson, Arizona, United States
🇺🇸
Pediatric Clinic, Arizona Health Sciences Center, Tucson, Arizona, United States

Personalized Exercise for Adolescents With Diabetes

Phase 1

Completed

Conditions: Diabetes

Interventions: Behavioral: PEP intervention

First Posted Date: 2008-05-29

Last Posted Date: 2014-05-20

Lead Sponsor: University of Arizona

Target Recruit Count: 39

Registration Number: NCT00686283

Locations: 🇺🇸
University Medical Center, Tucson, Arizona, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy